Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 410 of 6351
-
Could a painkiller stop the cough that Won't quit in lung fibrosis?
Symptom relief Recruiting nowThe primary purpose is to evaluate the safety and efficacy of NAL ER for the treatment of chronic cough in participants with Idiopathic Pulmonary Fibrosis (IPF).
Phase 3 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
A simple blood draw could detect bladder Cancer's return — a trial puts it to the test
Knowledge-focused Recruiting nowThis study investigates the feasibility of the Labcorp Plasma Detect, which is an assay (test) that looks for circulating tumor DNA (ctDNA) in patients who have muscle-invasive (MI) urothelial carcinoma (also known as MI bladder cancer, MIBC). During this study, tissue, blood and…
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can a safer nerve block match the gold standard for Post-Mastectomy pain?
Symptom relief Recruiting nowPostoperative pain management is crucial for patients undergoing mastectomy for breast cancer. Regional analgesia techniques, such as the Thoracic Paravertebral Block (TPVB), are commonly used to reduce pain and opioid consumption; however, TPVB carries potential risks, including…
Sponsor: Dharmais National Cancer Center Hospital • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Double-Targeting antibody takes on Hard-to-Treat throat cancer
Disease control Recruiting nowThis study is to determine the activity and tolerability of JS207 as a single agent and in combination cohort with chemotherapy. This is an open-labelled, phase Ib/II study of JS207 in patients with previously treated recurrent or metastatic nasopharyngeal carcinoma. The study wi…
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for bile duct cancer: experimental drug faces final test
Disease control Recruiting nowThis trial is a registrational Phase III, randomized, open-label, multicenter study to evaluate the efficacy and safety of BL-B01D1 compared with the investigator's choice of protocol in patients with locally advanced or metastatic biliary tract cancer who have failed prior plati…
Phase 3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Which brain target eases Parkinson's symptoms best? a Head-to-Head test
Disease control Recruiting nowThis prospective, randomized, participant- and outcome-assessor-blinded, parallel-group exploratory trial will compare the target-dependent clinical, neuroimaging, and electrophysiological effects of temporal interference stimulation (TIS) targeting the subthalamic nucleus (STN) …
Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug could help kidney transplant patients avoid rejection
Disease control Recruiting nowThe goal of this clinical trial is to learn if siplizumab can prevent rejection of a kidney transplant in adult participants with end stage kidney disease. The main questions it aims to answer are: How many adverse events do participants receiving two different doses of siplizum…
Phase 2 • Sponsor: Nefro Avillion Clinical Development, LLC • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Smarter heart pacing could cut hospital stays for heart failure patients
Disease control Not yet recruitingThe goal of this observational study is to evaluate the long-term clinical outcomes of physiologic cardiac resynchronization therapy (CRT) using conduction system pacing strategies compared with conventional biventricular CRT in patients with heart failure with reduced ejection f…
Sponsor: University of Pecs • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug aims to calm severe eczema without steroids
Disease control Recruiting nowThis is an interventional, randomized, parallel group, treatment, Phase 3, double blind study to assess the effect of Rezpegaldesleukin in participants 12 years of age or older with moderate to severe atopic dermatitis, as compared to placebo. The estimated participant overall d…
Phase 3 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a new tracer light up tumors better than standard PET scans?
Diagnosis By invitation onlyThis is a prospective, single-center, open-label, two-cohort clinical study evaluating the safety, tolerability, biodistribution, radiation dosimetry, and diagnostic performance of \[68Ga\]Ga-ELI411 PET imaging in adult patients with solid tumors. Eligible patients with an indica…
Early phase 1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
Can modified music tunes boost balance in kids with cerebral palsy?
Symptom relief OngoingThis study evaluates whether adding Therapeutic Listening to a structured physiotherapy program can improve balance, trunk control, and reaction time in children with spastic diplegic cerebral palsy. Children with spastic diplegic cerebral palsy may have difficulties with balanc…
Sponsor: MTI University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Precision radiotherapy may buy time for men with spreading prostate cancer
Disease control Recruiting nowPSMA-OLIGO-PRO is a multicenter ambispective observational real-world registry evaluating outcomes after PSMA PET-guided progression-directed radiotherapy for oligoprogressive prostate cancer. The registry includes retrospectively identified patients treated before June 26, 2026 …
Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New combo therapy aims to keep hepatitis b in check
Disease control Not yet recruitingThis is a multicenter, single-arm, open-label, phase IIIb extension clinical trial designed to evaluate the long-term safety and tolerability of GST-HG141 (nerlecovir, 50 mg BID) in combination with nucleos(t)ide analogues (NAs) in patients with chronic hepatitis B (CHB) who comp…
Phase 3 • Sponsor: Fujian Akeylink Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could simple Over-the-Counter drugs supercharge cancer immunotherapy?
Disease control Recruiting nowThis study evaluates whether optimization of ancillary therapies can improve the efficacy of immune checkpoint therapy in participants with solid tumors. The ancillary therapies being optimized include the avoidance of daily acetaminophen and cannabis/THC/CBD while prescribing as…
Phase 2 • Sponsor: Val Adams • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New daily pill aims to tackle Hard-to-Treat lymphoma
Disease control Not yet recruitingThis is an open-label, first-in-human dose escalation and dose expansion Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of HP-002 in patients with relapsed or refractory B-Cell Non-Hodgkin Lymphoma This study consists of …
Phase 1/2 • Sponsor: Shanghai Helioson Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New lung drug faces off against standard treatment in major trial
Disease control Recruiting nowThis is a study for adults with a lung disease called idiopathic pulmonary fibrosis. The main purpose of this study is to look at how well deupirfenidone improves lung function and how safe it is for people with idiopathic pulmonary fibrosis (IPF) when compared with pirfenidone. …
Phase 3 • Sponsor: PureTech • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Metaverse meets microsurgery: XR platform aims to sharpen brain bypass precision
Disease control Recruiting nowThis study will evaluate the application of a metaverse-based surgical simulation platform in extracranial-intracranial (EC-IC) bypass surgery. The study population will include patients with moyamoya disease or chronic cerebral ischemia who are scheduled to undergo EC-IC bypass …
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can removing clots from tiny brain arteries boost stroke recovery?
Disease control Recruiting nowThe objective of this study is to collect safety and effectiveness data on the Penumbra System reperfusion catheters in participants with isolated primary non-dominant and distal M2 occlusions who undergo endovascular mechanical thrombectomy (EVT). Additionally, this study aims t…
Sponsor: Penumbra Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Sound waves vs. chronic pain: a new test for CRPS after wrist fracture
Symptom relief Recruiting nowComplex regional pain syndrome type I (CRPS-I) can develop after a distal radius fracture and may cause persistent pain, swelling, limited wrist and hand movement, and difficulty using the affected upper limb. This study will evaluate whether extracorporeal shock wave therapy (ES…
Sponsor: Dilek ün oguzhanasilturk • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can a simple exercise program boost brain and balance in aging minds?
Symptom relief Recruiting nowolder adults with mild and moderate cognitive impairment. compare immediate vs progressive standing dual-task training. assess balance, cognition, executive function, mobility, and quality of life.
Sponsor: Shifa Tameer-e-Millat University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC